Trends in outpatient visits and deaths due to congenital heart defects in Peru.

Introduction: Congenital heart defects (CHD) are the most frequent congenital birth defects, affecting approximately 1% of newborns and constituting the main cause of death among all congenital malformations. The prevalence of CHD in Andean America is heterogeneous and in Peru the burden of CHD is unknown.

Objective: To describe the trends of CHD outpatient visits and mortality and their variation according to sex, age and altitude levels.

[The adult with tetralogy of fallot: what the clinical cardiologist needs to know].

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease. After more than seven decades of the first palliative surgery, TOF prognosis has changed dramatically. The prevalence of TOF is approximately 3 per 10 000 births, representing 7 to 10% of congenital heart disease.

Effects and safety of SGLT2 inhibitors compared to placebo in patients with heart failure: A systematic review and meta-analysis.

Background: Heart failure (HF) prognosis without therapy is poor, however introduction of a range of drugs has improved it. We aimed to perform a systematic review on the effects and safety of sodium-glucose transporter 2 inhibitors (SGLT2i) in HF patients.

Methods: We carried out a systematic review of randomized controlled trials (RCTs) on SGLT2i compared to placebo for HF patients.

Percutaneous endovascular management of ascending aortic pseudoaneurysm after heart transplantation in a pediatric patient.

Ascending aortic pseudoaneurysm is a rare complication after HT. Surgery is the most conventional management, but in some patients, it is risky. We report the case of a ten-year-old child who underwent HT and developed an ascending aortic pseudoaneurysm in the aortic anastomosis.